Annual Report 2023

CONSOLIDATED STATEMENT OF FINANCIAL POSITION At 31 December 2023 43 The United Laboratories International Holdings Limited Annual Report 2023 2023 2022 NOTES RMB’000 RMB’000 Non-current liabilities Deferred tax liabilities 30 288,080 194,069 Deferred income in respect of government grants 26 & 34 32,237 43,413 Derivative financial instruments 36 19,191 – Lease liabilities 28 4,322 3,896 Borrowings – due after one year 29 1,299,000 1,095,789 1,642,830 1,337,167 12,747,618 10,609,431 Capital and reserves Share capital 31 16,965 16,965 Reserves 12,717,813 10,591,121 Equity attributable to owners of the Company 12,734,778 10,608,086 Non-controlling interests 12,840 1,345 Total equity 12,747,618 10,609,431 The consolidated financial statements on pages 40 to 153 were approved and authorised for issue by the Board of Directors on 26 March 2024 and are signed on its behalf by: TSOI HOI SHAN LEUNG WING HON DIRECTOR DIRECTOR